The Development of Biological Markers for the Diagnosis of Alzheimer’s Disease
- 30 April 1998
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 19 (2) , 127-129
- https://doi.org/10.1016/s0197-4580(98)00016-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?Neurology, 1996
- Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body diseaseNeurology, 1996
- Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections.Radiology, 1996
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's DiseaseNeurology, 1995
- The Natural History of Alzheimer's DiseaseArchives of Neurology, 1994
- Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part III. Reliability of a standardized MRI evaluation of Alzheimer's diseaseNeurology, 1992
- Clinically Diagnosed Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1992
- Technology assessment revisitedNeurology, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984